Ian Morton is a partner at Crimson Investment, an international private-equity firm that was founded in 1993 and has $600 million under management. Headquartered in the Palo Alto, Calif., with offices in Taipei, Taiwan, and Shanghai, China, Crimson provides buyout financing to companies capitalizing on the accelerating globalization trend within the manufacturing and services industries.
Crimson (www.crimsoninvestment.com) acquires U.S. companies and partners with management to actively help them establish offshore Pacific Rim sourcing, production, and service capabilities. In late 2001, the firm helped to engineer the sale of 9,000-employee, Singapore-based injection molder Omni Industries Ltd. by Toronto-based electronics contract manufacturer Celestica Inc.
Prior to joining Crimson, Morton sourced and evaluated private-equity investments for JP Morgan Chase for more than 10 years and served as a senior research analyst covering supply-chain service companies within the contract manufacturing, distribution and components industries. He has been widely quoted in financial and industry publications, including Forbes, Fortune, BusinessWeek, The Wall Street Journal and Barron's, among others. Morton received his bachelor of arts degree in history from Middlebury College.